| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 2 securities · may seek to influence control | ||||||
|
Lifecore Biomedical, Inc.
13D/A
LFCR · 514766104
|
14.3% |
9/29/2026
Event 9/27/2026
|
||||
| Wynnefield Partners Small Cap Value, L.P. I | 6.3% | |||||
| Wynnefield Partners Small Cap Value, L.P. | 4.1% | |||||
| Wynnefield Small Cap Value Offshore Fund, Ltd. | 2.7% | |||||
| Wynnefield Capital, Inc. Profit Sharing & Money Purchase Plan | 1.0% | |||||
| Wynnefield Capital Management, LLC | 10.3% | |||||
| Wynnefield Capital, Inc. | 2.7% | |||||
| Nelson Obus | 14.3% | |||||
| Joshua Landes | 13.9% | |||||
|
TechPrecision Corporation
13D/A
TPCS · 878739101
|
4.5% |
12/23/2024
Event 12/19/2024
|
||||
| Wynnefield Partners Small Cap Value, L.P. I | 1.9% | |||||
| Wynnefield Partners Small Cap Value, L.P. | 1.2% | |||||
| Wynnefield Small Cap Value Offshore Fund, Ltd. | 0.8% | |||||
| Wynnefield Capital, Inc. Profit Sharing Plan | 0.7% | |||||
| Wynnefield Capital Management, LLC | 3.1% | |||||
| Wynnefield Capital, Inc. | 0.8% | |||||
| Nelson Obus | 4.5% | |||||
| Joshua H. Landes | 4.5% | |||||
| Robert D. Straus | 2.1% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.